SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-211983
Filing Date
2018-07-03
Accepted
2018-07-03 08:33:04
Documents
2
Period of Report
2018-07-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d466633d8k.htm 8-K 18305
2 EX-10.1 d466633dex101.htm EX-10.1 273409
  Complete submission text file 0001193125-18-211983.txt   292988
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 18934757
SIC: 2834 Pharmaceutical Preparations